Global Management of Chronic Renal Insufficiency (CRI):
Practical Issues


World Congress of Nephrology (ASN/ISN), San Francisco, CA, October, 2001
Access to this program is free but HDCN free zone registration is required.
Demystifying Anemia Management in Chronic Renal Insufficiency
Daniel W. Coyne, M.D.
Calcium Phosphate and Bone:
Avoiding the Pitfalls
in Chronic Renal Insufficiency

Jill S. Lindberg, M.D.

After participating in this activity, participants should be able to:

Identify the challenges in caring for patients with CRI
Discuss treatment options used to improve CRI patient outcomes
Review the latest clinical data and developments in managing anemia in CRI patients

Daniel W. Coyne, M.D.
Associate Professor of Medicine, Washington University; Director, Hemodialysis, Chromalloy American Kidney Center; Director, Renal Outpatient Renal Clinics; Co-director, Renal Fellowship Training Program, St. Louis, MO.

Jill S. Lindberg, M.D.
Assistant Clinical Professor of Medicine, Tulane University, New Orleans, LA. Assistant Clinical Professor of Medicine, Louisiana State University of New Orleans, LA. Associate Section Head, Hemodialysis Units Director, Metabolic Bone and Stone Clinics. Director, Nephrology Research, Ochsner Foundation Hospital, New Orleans, LA.

ACCREDITATION / DESIGNATION STATEMENT(S) :

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Medical Education Resources, Inc. Medical Education Resources, Inc. is accredited by the ACCME to sponsor continuing medical education for physicians and takes responsibility for the content, quality, and scientific integrity of this CME activity.

Medical Education Resources, Inc. designates this educational activity for a maximum of 1.25 hours in Category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.


Nursing Accreditation
This CE activity is approved for 1.25 contact hours. Medical Education Resources, Inc. is approved as a provider of continuing education in nursing (CNE) by the Colorado Nurses Association, which is accredited as an approver of CNE by the American Nurses Credentialing Center's Commission on Accreditation.

Provider approved by the California Board of Registered Nursing, Provider #CEP 12299, for 1.25 contact hours.

INSTRUCTIONS FOR CME CREDIT :

To earn CME credit for viewing the lectures, please print and complete the CME Posttest questions and return with the completed Evaluation Form to Medical Education Resources, Inc. via fax at (303) 798-5731 or mail at 1500 West Canal Court, Suite 500, Littleton, Colorado 80120-5617.

Post-test and Evaluation Form are at this link, but you must listen to all four talks from this symposium prior to completing the test.

TARGET AUDIENCE :
This program is designed for clinicians who are involved in the care of chronic renal insufficiency

FACULTY DISCLOSURE STATEMENTS :
All faculty participating in continuing medical education programs are expected to disclose to the program audience any real or apparent conflict of interest related to the subject under discussion. The faculty disclosure information is as follows:
Daniel W. Coyne, MD, has received grants/research support from Amgen and is a consultant and Speaker Bureau participant for Watson Pharmaceuticals, Inc.
Jill S. Lindberg, MD, has received grants/research support from and is a consultant for Genzyme, Amgen, and BCI.

DISCLOSURE OF UNLABELED USE ASN/HDCN (if applicable):
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by FDA. Medical Education Resources, ASN, HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
All of the agents overviewed in this virtual symposium will be discussed in the context of uses for which they have not been approved by the FDA.

This educational activity is supported by an educational grant from Watson Pharmaceuticals Inc.
This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.
This educational activity is based on an ASN/ISN evening symposium which was
planned by the World Congress of Nephrology program committee.
BACK TO
TOPIC INDEX :